-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Up 5%
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Up 5%
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating)'s stock price traded up 5% during mid-day trading on Thursday . The company traded as high as $0.71 and last traded at $0.63. 2,926 shares traded hands during trading, a decline of 36% from the average session volume of 4,598 shares. The stock had previously closed at $0.60.
ZIVO Bioscience Trading Up 5.0 %
The business has a fifty day moving average price of $0.77 and a 200-day moving average price of $0.73.
Get ZIVO Bioscience alerts:Institutional Trading of ZIVO Bioscience
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
About ZIVO Bioscience
(Get Rating)
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
Featured Stories
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating)'s stock price traded up 5% during mid-day trading on Thursday . The company traded as high as $0.71 and last traded at $0.63. 2,926 shares traded hands during trading, a decline of 36% from the average session volume of 4,598 shares. The stock had previously closed at $0.60.
ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的股價在週四午盤交易中上漲了5％。該公司的交易價格高達0.71美元，最後一次交易價格爲0.63美元。交易期間交易了2,926股，較平均交易量4598股下降了36％。該股此前收於0.60美元。
ZIVO Bioscience Trading Up 5.0 %
ZIVO Bioscience 交易上漲5.0％
The business has a fifty day moving average price of $0.77 and a 200-day moving average price of $0.73.
該企業的五十天移動平均價格爲0.77美元，200天移動平均價格爲0.73美元。
Institutional Trading of ZIVO Bioscience
ZIVO 生物科學的機構交易
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its stake in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,654 shares of the company's stock after purchasing an additional 69,034 shares during the period. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
一位機構投資者最近提高了其在ZIVO Bioscience股票中的頭寸。根據向美國證券交易委員會（SEC）提交的最新文件，Warberg Asset Management LLC在第三季度將其在ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的股份增加了442.0％。該基金在此期間又購買了69,034股股票後，擁有該公司84,654股股票。截至最近報告期末，Warberg Asset Management LLC在ZIVO Bioscience的持股價值51,000美元。
About ZIVO Bioscience
關於 ZIVO 生物科學
(Get Rating)
（獲取評分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc 是一家總部位於密歇根州的生物技術/農業科技公司，致力於利用其專有藻類培養物的生物活性化合物的免疫健康和營養益處。開發渠道包括用作膳食補充劑和功能性食品原料的天然產品，以及旨在爲人類和動物提供藥物和藥物功效的創新、生物衍生和合成的候選產品，特別側重於調節免疫和炎症反應。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 3 April Earnings Plays for Bullish Swing Traders
- Is Constellation Brands Star About To Rise?
- 免費獲取 StockNews.com 關於 ZIVO Bioscience (ZIVOW) 的研究報告的副本
- Hypercharge Networks：上漲了三位數，但有甚麼大不了的？
- 蘋果30％的漲勢有長足的3個原因
- 選擇原住民而不是第一共和國銀行的3個理由
- 4月3日財報爲看漲的波段交易者帶來了樂觀
- 星座品牌之星即將崛起嗎？
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 ZIVO 生物科學日報的新聞和收視率 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收ZIVO Bioscience及相關公司最新新聞和分析師評級的簡明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧